PAR-23-049: NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2022.
National Institutes of Health offered grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on November 17, 2025.
From the official notice on Grants.gov, last changed December 28, 2022. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeGrant
About this NIH notice
- Activity codeP30
- Clinical trialsOptional
- Funded byNIDA
- Median yearly award$349,182
- Typical project length17.5 years
- P30, Center Core Grant. Shared facilities and services for investigators who already hold research funding on a common theme. Other open P30 notices.
Projects funded under PAR-23-049 were run by National Institute on Drug Abuse (NIDA, 9 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read PAR-23-049 in the NIH Guide.
Key dates
| Posted | December 28, 2022 |
|---|---|
| Deadline | November 17, 2025 |
| Archived by Grants.gov | December 23, 2025 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
All 15 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Is this a realistic fit?
- Most of the program's money (70% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
NIDA Core Center of Excellence Grants (P30) are intended to bring together investigators currently funded by NIH or other Federal or non-Federal sources, to enhance the effectiveness of existing research and also to extend the focus of research to drug abuse and addiction. It is expected that a Center will transform knowledge in the sciences it is studying. Incremental work should not be the focus of Center activities; rather, new and creative directions are encouraged. An application should integrate and promote research in existing funded projects, to achieve new and creative directions. It is expected that individual core activities reflect a relationship to the integrating theme of the Center and the Center is expected to provide research opportunities and experiences to new investigators , and share findings, data and their resources, consistent with achieving the goals of the program.
Funded under PAR-23-049 so far
NIH funded 9 projects under PAR-23-049 in fiscal 2024 to 2026, at 9 institutions. The median yearly award was $349,182.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| Bioinformatics and Biostatistics Core | Yale University | 2026 | $357,945 |
| Bioanalytical Core | Virginia Commonwealth University | 2026 | $252,714 |
| Administrative Core | Dartmouth College | 2026 | $519,610 |
| SAM Core | University of Colorado Denver | 2026 | $316,619 |
| Neurometabolomics and Neuroproteomics Center on Cell-Cell Signaling | University of Illinois at Urbana-Champaign | 2026 | $1.1 million |
| Administrative Core | University of Minnesota | 2026 | $393,031 |
| Center for Integrative Addiction Neurobiology (CIAN) | Temple Univ of the Commonwealth | 2026 | $2.0 million |
| Core A | University of California, San Diego | 2026 | $338,204 |
Who has won Drug Use and Addiction Research Programs grants before
From fiscal 2021 to 2025, Drug Use and Addiction Research Programs (93.279) awarded $7.3 billion across 5,071 grant awards, an average of $1.4 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Yale Univ | Connecticut | 150 | $305 million |
| The Johns Hopkins University | Maryland | 156 | $262 million |
| University of California, San Diego | California | 120 | $242 million |
| University of Pittsburgh - of the Commonwealth System of Higher Education | Pennsylvania | 100 | $182 million |
| New York University | New York | 62 | $173 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is PAR-23-049 still open?
No. It closed on November 17, 2025.
Who can apply for NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)?
National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)?
Closed November 17, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has been funded under PAR-23-049?
NIH RePORTER lists 9 projects funded under PAR-23-049 in fiscal 2024 to 2026, at 9 institutions. The most were at Yale University, Virginia Commonwealth University, Dartmouth College.
Who has won Drug Use and Addiction Research Programs grants before?
The largest recipients over five fiscal years were Yale Univ, The Johns Hopkins University, University of California, San Diego. The program made 5,071 awards worth $7.3 billion in that time.
Similar open grants
- Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
- Diabetes Research Centers (P30 Clinical Trial Optional)
- KUH P30 Resource Core Center (P30 Clinical Trial Not Allowed)
- Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)
- Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional)
- AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)